Banner

Ep. 68: Hidden risks of prescribing GLP-1 drugs with Ericka L. Adler, J.D., of Roetzel & Andress

News
Podcast

Ericka Adler, J.D., a health care attorney with Roetzel & Andress, joins the show to explore the legal risks of prescribing GLP-1 medications.

Ericka L. Adler, J.D., a health care attorney and practice group manager with Roetzel & Andress, joins the show to break down the hidden legal risks of prescribing GLP-1 medications that physicians need to know about, from ensuring informed consent to navigating long-term safety data.

Don't miss our previous episodes on immigration policy and the physician shortage, AI diagnostic tools, patient autonomy and malpractice law.

Music Credits:
After Hours by Yigit Atilla - stock.adobe.com
Relaxing Lounge by Classy Call me Man - stock.adobe.com
COCKTAIL by Mythical Audio - stock.adobe.com

Editor's note: Episode timestamps and transcript produced using AI tools.

**Introduction and Overview (00:00:00)**
Brief mention of compliance issues and the evolving legal landscape for prescribing GLP-1 drugs.

**Podcast Introduction (00:00:29)**
Host introduces the episode, speakers, and main topics: legal risks, informed consent, and safety data for GLP-1 drugs.

**Guest Introduction (00:01:05)**
Introduction of EricKa Adler and the focus on GLP-1 drug risks.

**Liability Risks for Prescribing GLP-1 Drugs (00:01:19)**
Discussion of primary legal risks, compliance with state and federal laws, and proper office setup.

**Off-Label Use Legal Concerns (00:02:49)**
Explains legal concerns with off-label prescribing and how to mitigate risks through documentation and informed consent.

**Informed Consent Specifics for GLP-1 Drugs (00:05:53)**
Importance of tailored, robust informed consent forms for GLP-1 drugs, especially for off-label use.

**Compounded Versions and Legal Risks (00:07:57)**
Legal risks of prescribing compounded GLP-1 drugs, including contamination, misbranding, and advertising issues.

**Insurance Denials and Prior Authorizations (00:11:26)**
Challenges with insurance coverage, prior authorizations, and evolving insurer policies for GLP-1 prescriptions.

**Telemedicine and Prescribing GLP-1 Drugs (00:14:10)**
Legal risks and compliance requirements for prescribing GLP-1 drugs via telemedicine, including licensure and administration rules.

**Long-Term Safety and Liability Concerns (00:16:59)**
Emerging liability concerns regarding long-term safety and adverse effects, and the importance of malpractice coverage.

**Financial Relationships with Pharmaceutical Companies (00:20:10)**
Legal and ethical concerns for physicians with financial ties to GLP-1 drug manufacturers, including anti-kickback laws.

**Regulatory Changes and Evolving Landscape (00:21:40)**
Recent and anticipated legal or regulatory changes, state vs. federal oversight, and the need for ongoing compliance.

**Conclusion and Closing Remarks (00:25:02)**
Thanking the guest, closing the episode, and providing subscription information.

Recent Videos
Practice lessons from the works of Mark Twain
Practice lessons from the works of Mark Twain
Using AI agents
Jennifer Wiggins
Using AI agents
Resurrecting the handshake
Jennifer Wiggins
Practice lessons from the works of Mark Twain
Using AI agents
Using AI agents
© 2025 MJH Life Sciences

All rights reserved.